TSAI LARRY (Chief Medical Officer) received a stock award from TETRAPHASE PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/18/2019ACC: 0001209191-19-004609
Officer· Chief Medical Officer
Since Jan 2019
+185.40K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
185.40K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.06K
Price / share
—
Trade value
—
% of position
6.5%
5/14/2018
31.50K→33.56K
Common Stock
Direct
Shares
+3.34K
Price / share
—
Trade value
—
% of position
11.8%
1/6/2019
28.17K→31.50K
Total
Net shares
+5.39K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2018 | A · Award | +2.06K | — | — | 6.5% | 31.50K | 33.56K |
| Common Stock Direct | 1/6/2019 | A · Award | +3.34K | — | — | 11.8% | 28.17K | 31.50K |
| Total | +5.39K | $0.00 | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
40K shares
Shares
+40K
Strike price
Held after
40K
Exercisable
—
1/17/2019
Restricted Stock Units
Direct
Converts to
Common Stock
140K shares
Shares
+140K
Strike price
Held after
140K
Exercisable
—
1/17/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock40K shares | 1/17/2019 | A · Award | +40K | — | 40K | |
| Restricted Stock Units Direct | Common Stock140K shares | 1/17/2019 | A · Award | +140K | — | 140K |